| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.65B | +31.5% |
| Cost of Revenue | $1.67B | +29.5% |
| R&D Expense | $49.9M | +42.1% |
| SG&A Expense | $228.4M | +7.0% |
| Operating Income | $194.4M | +340.7% |
| Interest Expense | $177.9M | +3.7% |
| Pre-tax Income | -$245.7M | +49.7% |
| Income Tax | $61.5M | +10.6% |
| Net Income | -$350.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $451.0M | -54.5% |
| Short-term Investments | $1.3M | +7488.2% |
| Accounts Receivable | $327.4M | +13.8% |
| Inventory | $127.9M | +1.2% |
| Current Assets | $1.00B | -34.1% |
| Total Assets | $4.73B | -14.4% |
| Current Liabilities | $596.4M | +13.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $501.1M | +16.9% |
| Capital Expenditures | $373.4M | +59.6% |
| Investing Cash Flow | -$368.7M | -214.5% |
| Financing Cash Flow | -$661.5M | -235.4% |
| Free Cash Flow | $127.6M | -34.5% |
| +38.5% |
| EPS (Basic) | -$40.52 | +47.1% |
| EPS (Diluted) | -$40.52 | +47.1% |
| Long-term Debt |
| $2.54B |
| -22.2% |
| Total Liabilities | $3.51B | -14.9% |
| Stockholders' Equity | $369.0M | -37.5% |